> ## Content Index > Fetch the complete content index at: https://newsletters.qs.com/llms.txt > Use this file to discover other available public pages before exploring further. # ⚕️ Health Futures #27 - URL: https://newsletters.qs.com/health-futures-27/ - Published: 2024-07-22T09:43:22.000Z - Updated: 2024-07-22T09:43:22.000Z - Description: HolonIQ's Health Newsletter dives into the latest developments in the healthcare services, health hardware and systems, and biotechnology sectors, and highlights the week's top energy deals. - Author: QS - Tags: Health Skills **Happy Monday 👋** On the back of the recent UK elections, the NHS released several [new measures ](https://www.medicaldevice-network.com/news/nhs-look-to-roll-out-hpv-self-testing-kits-after-youseek-trial/?ref=newsletters.qs.com)targeted to increase its diagnostic capabilities and improve overall population health in the UK. AI continues to gain traction in health, where [Kaiser Permanente has integrated Gen AI](https://venturebeat.com/ai/how-kaiser-permanente-is-using-gen-ai-to-paradoxically-make-care-more-human-again/?ref=newsletters.qs.com) into its clinical and non-clinical workflows to achieve more efficient operations. Major medical devices made headways in remote patient monitoring, with [Phillips partnering with Bon Secours](https://www.healthcareitnews.com/news/bon-secours-taps-philips-10-year-patient-monitoring-collaboration?ref=newsletters.qs.com) to provide its monitoring systems across 49 hospitals in seven states. In Biotechnology and Pharmaceuticals, cell therapy continues to attract attention as [Vertex Pharmaceuticals collaborates with Orum Therapeutics](https://my.holoniq.com/developments/HDVBJQYDABXD3ZDW3PBF/?ref=newsletters.qs.com). In this week's health deals, J&J continues to expand its MedTech portfolio through its [$1B](https://www.biopharminternational.com/view/johnson-johnson-completes-numab-subsidiary-acquisition-boosts-bispecific-antibody-pipeline?ref=newsletters.qs.com) acquisition of Numab Therapeutics. Health tech firms that produce interventions for chronic continue to garner investor interest. Scorpion Therapeutics secured [$150M](https://www.fiercebiotech.com/biotech/scorpion-snaps-150m-series-c-funds-widen-clinical-plans-cancer-pipeline?ref=newsletters.qs.com) for its oncology therapeutic development, and Cardurion Pharmaceuticals raised [$260M](https://www.finsmes.com/2024/07/cardurion-pharmaceuticals-raises-260m-series-b-financing.html?ref=newsletters.qs.com) to develop cardiovascular medications. ## 🧑‍⚕️ Healthcare **👩‍⚕️ NHS to Introduce HPV Self-testing Kits for Cervical Screening**. A major UK trial demonstrated that [providing](https://www.medicaldevice-network.com/news/nhs-look-to-roll-out-hpv-self-testing-kits-after-youseek-trial/?ref=newsletters.qs.com) self-testing kits for HPV can increase women's participation by 400,000 per annum in cervical cancer screening programs. The NHS is considering rolling out these self-testing kits nationwide. 🏥 **Kaiser Permanente Integrated Gen AI Into Healthcare Services**. Kaiser Permanente is [utilizing](https://venturebeat.com/ai/how-kaiser-permanente-is-using-gen-ai-to-paradoxically-make-care-more-human-again/?ref=newsletters.qs.com) generative AI technologies, such as alert monitoring and scribe tools, to improve the experiences of both patients and healthcare professionals. 🏥 **Atlas Healthcare Partners and Multicare Health System to Establish a Surgery Center Network.** Atlas Healthcare Partners, a national ambulatory surgery center development and management company, announced a[ joint venture](https://www.prnewswire.com/news-releases/atlas-healthcare-partners-announces-joint-venture-with-multicare-health-system-to-develop-an-ambulatory-surgery-center-network-in-the-pacific-northwest-302197276.html?ref=newsletters.qs.com) with MultiCare Health System to develop an ambulatory surgery center network in the Pacific Northwest region. ## 🖥️ Hardware and Systems **🏥 Bon Secours Partners With Philips for Patient Monitoring.** Bon Secours, a seven-state health system, [partnered ](https://www.healthcareitnews.com/news/bon-secours-taps-philips-10-year-patient-monitoring-collaboration?ref=newsletters.qs.com)with Philips for a 10-year collaboration to standardize patient monitoring tools and processes across its 49 hospitals and hundreds of care sites. 🔬 **FUJIFILM Healthcare Europe Introduced a Medical Imaging Feature.** FUJIFILM Healthcare Europe [announced ](https://www.globenewswire.com/news-release/2024/07/16/2913488/0/en/FUJIFILM-Healthcare-Europe-announces-revolutionary-Detective-Flow-Imaging-DFI-technology-compatibility-with-mainstream-EG-580UT-endoscope.html?ref=newsletters.qs.com)a new Detective Flow Imaging (DFI) feature for its medical imaging solutions. 🧠 **NHS Recommended to Use Digital Tech for ADHD Diagnosis.** The National Institute for Health and Care Excellence (NICE) [recommended](https://pharmaphorum.com/news/nhs-course-use-digital-tech-diagnose-adhd?ref=newsletters.qs.com) that the NHS use the digital diagnostic tool QbTest as an add-on to standard assessment for diagnosing Attention Deficit Hyperactivity Disorder (ADHD). This is a push to adopt digital methods into population health management. ## 💊 Biopharma **💉 Sanofi Expanded Hyderabad Site With $437M Investment**. Sanofi, a pharmaceutical company, is [investing ](https://www.fiercepharma.com/pharma/sanofi-double-its-workforce-hyderabad-india-437m-expansion-investment?ref=newsletters.qs.com)$437M to expand its workforce and utilize artificial intelligence. The company plans to increase the site's workforce from 1,000 to 2,600 employees over the next two years. **🔬 Vertex Partners With South Korean Biotech for Gene Editing.** Vertex Pharmaceuticals signed a[ deal ](https://my.holoniq.com/developments/HDVBJQYDABXD3ZDW3PBF/?ref=newsletters.qs.com)with Orum Therapeutics, a biotech company with offices in Lexington and South Korea, to develop conditioning agents for gene editing using Orum's technology. **💊 Boehringer Ingelheim and GoodRx Partner.** Boehringer Ingelheim, a pharmaceutical company, and GoodRx, a prescription savings platform, have announced an exclusive[ partnership](https://www.biopharmadive.com/news/boehringer-goodrx-Humira-biosimilar-price-cut/721713/?ref=newsletters.qs.com) to improve patient affordability for Adalimumab-adbm, Boehringer's biosimilar to Humira. ## **💰** Deals of the Week 💊 **Johnson & Johnson** has [acquired](https://www.biopharminternational.com/view/johnson-johnson-completes-numab-subsidiary-acquisition-boosts-bispecific-antibody-pipeline?ref=newsletters.qs.com) Numab Therapeutics, adding NM26, a Phase II bispecific antibody for atopic dermatitis, to its portfolio. 💊 **NGM Bio**, a biotechnology company, [raised ](https://www.biopharmadive.com/news/ngm-series-a-raise-column-group-aldafermin/721457/?ref=newsletters.qs.com)$122M in a Series A financing round led by The Column Group to develop treatments for primary sclerosing cholangitis, a rare liver disease. 💰 **Scorpion Therapeutics**, a US-based clinical-stage oncology company, [raised](https://www.finsmes.com/2024/07/scorpion-therapeutics-raises-150m-in-series-c-financing.html?ref=newsletters.qs.com) $150 million in Series C funding to advance its clinical-stage EGFR inhibitor franchise, including STX-721 and STX-241, and its discovery pipeline of next-generation precision oncology therapies. **💰 Scorpion Therapeutics**, a US-based healthcare company, [raised](https://www.fiercebiotech.com/biotech/scorpion-snaps-150m-series-c-funds-widen-clinical-plans-cancer-pipeline?ref=newsletters.qs.com) $150M in a Series C funding round led by venture capital firms Frazier Life Sciences and Lightspeed Venture Partners. **💊 Cardurion Pharmaceuticals**, a US-based clinical-stage biotechnology company developing cardiovascular disease treatments,[ raised ](https://www.finsmes.com/2024/07/cardurion-pharmaceuticals-raises-260m-series-b-financing.html?ref=newsletters.qs.com)$260M in Series B financing to conduct later-stage clinical trials with its two lead drug candidates. --- **Thank you for reading. Have a great week ahead!** Have some feedback or suggestions? Let us know at hello@holoniq.com [ ](https://newsletters.qs.com/psychedelic-mental-health-treatments-south-asia-health-tech-100-2/)